When a top biopharma executive abruptly shoves off, what comes next? Questions. Make that departing exec a sales-and-marketing chief, and couple that departure with slowing sales of a key product, and ...

On Wednesday, Biogen Inc (NASDAQ:BIIB) reported first-quarter adjusted EPS of $3.67, up 8%, beating the consensus of $3.44. The company reported sales of $2.29 billion, down 7% year over year and ...

Biogen Inc.BIIB has appointed its present chief commercial officer (CCO), Michel Vounatsos, as the new chief executive officer (CEO), effective Jan 6, 2017. Vounatsos, who also holds the position of ...

Former Biogen executive Tony Kingsley will lead The Medicine Company’s daily operations and commercial activities. The Medicines Company named Tony Kingsley as president and chief operating officer.

Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: ...

Patient social network MyMSTeam has partnered with Biogen to create an education resource for its multiple sclerosis patients. The resource is focused on the lesser known effects MS has on cognition, ...